Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical Cancer

NCT01158248 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

BIOLOGICAL: panitumumab
DRUG: cisplatin
RADIATION: brachytherapy
RADIATION: external beam radiation therapy

Sponsor

Medical University Innsbruck